Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gilbert

Showing results (751-760 of 869) with videos related to

Pageof 87
Sort By:
Nature Communications|November 28, 2023
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01Yunda Huang, Lily Zhang, Shelly Karuna, et al.
Vaccine|October 27, 2016
A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trialT Hertz, M G Logan, M Rolland, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2024
Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric CancerChi-Lee C Ho, Michael B Gilbert, Guillaume Urtecho, et al.
American Journal of Human Genetics|January 24, 2004
Mutations within the MGC4607 gene cause cerebral cavernous malformationsC Denier, S Goutagny, P Labauge, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2013
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgGGeorgia D Tomaras, Guido Ferrari, Xiaoying Shen, et al.
Nature Medicine|September 1, 2015
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single foundersHolly Janes, Joshua T Herbeck, Sodsai Tovanabutra, et al.
Frontiers in Immunology|October 20, 2022
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in miceKatarina Blagovic, Carolyne K Smith, Amritha Ramakrishnan, et al.
Cell Host & Microbe|July 16, 2022
HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypeShuying S Li, Andrew Hickey, Shida Shangguan, et al.
Journal of Virology|August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine TrialShuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
The Lancet. HIV|November 28, 2025
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trialSusan P Buchbinder, Sabrina Spinosa Guzman, Jorge Sanchez, et al.
Pageof 87

Showing results (751-760 of 869) with videos related to

Sort By:
Pageof 87
Nature Communications|November 28, 2023
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01Yunda Huang, Lily Zhang, Shelly Karuna, et al.
Vaccine|October 27, 2016
A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trialT Hertz, M G Logan, M Rolland, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2024
Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric CancerChi-Lee C Ho, Michael B Gilbert, Guillaume Urtecho, et al.
American Journal of Human Genetics|January 24, 2004
Mutations within the MGC4607 gene cause cerebral cavernous malformationsC Denier, S Goutagny, P Labauge, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2013
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgGGeorgia D Tomaras, Guido Ferrari, Xiaoying Shen, et al.
Nature Medicine|September 1, 2015
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single foundersHolly Janes, Joshua T Herbeck, Sodsai Tovanabutra, et al.
Frontiers in Immunology|October 20, 2022
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in miceKatarina Blagovic, Carolyne K Smith, Amritha Ramakrishnan, et al.
Cell Host & Microbe|July 16, 2022
HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotypeShuying S Li, Andrew Hickey, Shida Shangguan, et al.
Journal of Virology|August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine TrialShuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
The Lancet. HIV|November 28, 2025
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trialSusan P Buchbinder, Sabrina Spinosa Guzman, Jorge Sanchez, et al.
Pageof 87